Coherus Oncology, Inc. (CHRS)
1.37
+0.02
(+1.48%)
USD |
NASDAQ |
Sep 21, 16:00
1.39
+0.02
(+1.46%)
After-Hours: 20:00
Coherus Oncology Price : 1.37 for Sept. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 21, 2026 | 1.35 | 1.43 | 1.30 | 1.37 | 1.489M |
| Sep 18, 2026 | 1.23 | 1.35 | 1.225 | 1.35 | 3.125M |
| Sep 17, 2026 | 1.26 | 1.27 | 1.18 | 1.23 | 1.887M |
| Sep 16, 2026 | 1.34 | 1.35 | 1.21 | 1.22 | 1.291M |
| Sep 15, 2026 | 1.38 | 1.39 | 1.32 | 1.33 | 761961.0 |
| Sep 14, 2026 | 1.34 | 1.43 | 1.34 | 1.43 | 1.275M |
| Sep 11, 2026 | 1.378 | 1.38 | 1.325 | 1.33 | 529193.0 |
| Sep 10, 2026 | 1.33 | 1.36 | 1.30 | 1.34 | 1.020M |
| Sep 09, 2026 | 1.34 | 1.375 | 1.31 | 1.32 | 840616.0 |
| Sep 08, 2026 | 1.40 | 1.43 | 1.36 | 1.37 | 549199.0 |
| Sep 04, 2026 | 1.38 | 1.435 | 1.38 | 1.42 | 306060.0 |
| Sep 03, 2026 | 1.42 | 1.43 | 1.36 | 1.37 | 437197.0 |
| Sep 02, 2026 | 1.37 | 1.435 | 1.355 | 1.42 | 621492.0 |
| Sep 01, 2026 | 1.36 | 1.40 | 1.35 | 1.37 | 695157.0 |
| Aug 31, 2026 | 1.39 | 1.41 | 1.30 | 1.35 | 1.128M |
| Aug 28, 2026 | 1.45 | 1.48 | 1.40 | 1.41 | 605088.0 |
| Aug 27, 2026 | 1.43 | 1.48 | 1.41 | 1.46 | 788317.0 |
| Aug 26, 2026 | 1.37 | 1.455 | 1.34 | 1.45 | 896541.0 |
| Aug 25, 2026 | 1.36 | 1.410 | 1.31 | 1.37 | 1.297M |
| Aug 24, 2026 | 1.43 | 1.43 | 1.35 | 1.36 | 1.046M |
| Aug 21, 2026 | 1.32 | 1.44 | 1.315 | 1.42 | 1.568M |
| Aug 20, 2026 | 1.31 | 1.34 | 1.27 | 1.32 | 740186.0 |
| Aug 19, 2026 | 1.379 | 1.405 | 1.295 | 1.33 | 3.038M |
| Aug 18, 2026 | 1.26 | 1.36 | 1.22 | 1.34 | 3.478M |
| Aug 17, 2026 | 1.20 | 1.200 | 1.13 | 1.15 | 1.265M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Enanta Pharmaceuticals, Inc. | 12.11 |
| ACADIA Pharmaceuticals, Inc. | 26.40 |
| Alnylam Pharmaceuticals, Inc. | 244.32 |
| Anika Therapeutics, Inc. | 20.70 |
| Savara, Inc. | 5.45 |
Price Related Metrics
| PS Ratio | 3.549 |
| Price to Book Value | 3.478 |
| Earnings Yield | -74.54% |
| Market Cap | 211.62M |